What are the treatment of atypical ductal hyperplasia?
The presence of abnormal cells in the female breast may result in diagnosis of atypical ductal hyperplasia, which is a non -disannitious condition in pectoral channels that can lead to cancer. The initial response to the condition is careful monitoring of abnormal cells. Mastectomy - surgical removal of breast with abnormal cells - is one of the treatments that doctors can propose if atypical ductal hyperplasia is present. Some women may decide to participate in clinical assessments recommended by their physician. Because the condition can lead to breast cancer, some women with high -risk factors can choose medication therapy to prevent the formation of the disease. Early detection of cancer cells can improve treatment. Surgery, clinical trials and drugs are other forms of treatment of atypical ductal hyperplasia.
When physical examination and biopsy - removal of sampling cells - indicate the possibility of forming breast cancer, the physician may initially initiate cell monitoring. The doctor usually checks during the pRavidly planned meetings to determine whether the cells develop into a tumor. Monitoring at home by performing monthly tests for self -confidence is another method that doctors can recommend in close monitoring.
undergoing mastectomy is a preventive measure to reduce the risk of breast cancer. Some women may decide to remove breasts if there are other risk factors such as a family history of cancer. Some women may have double mastectomy if examination and biopsy find atypical ductal hyperplasia. Removal of both breasts that are considered a drastic measure.
The physician may have access to clinical evaluation information that could be suitable for a woman with atypical ductal hyperplasia. Clinical studies can serve as a way to have access to advanced treatment before approval for extensive use. While participating in clinical evaluation do not guaranteeE Successful treatment, exposes a woman of advanced medical care.
Another possibility of treatment for atypical breast hyperplasia is hormone substitution therapy. Two of these drugs are tamoxifen and raloxifen, which are usually prescribed after menopause for hormone balance. Long -term use can prevent atypical ductal hyperplasia from breast cancer. These drugs are associated with possible side effects, including blood clots, vaginal dryness or stroke. Women should thoroughly discuss the disadvantages of side effects compared to the possibility of obtaining breast cancer with their doctor.